Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,185 | 8,344 | 12,369 | 15,644 | 8,404 |
| TOTAL | $47,330 | $8,915 | $13,195 | $16,526 | $9,241 |
| Non-Current Assets | |||||
| PPE Net | 131 | 67 | 67 | 63 | 5 |
| Intangibles | 7,647 | 7,647 | 7,647 | 7,647 | 7,647 |
| Other Non-Current Assets | 153 | 159 | 135 | 132 | 119 |
| TOTAL | $7,931 | $7,874 | $7,849 | $7,843 | $7,771 |
| Total Assets | $55,261 | $16,788 | $21,044 | $24,369 | $17,012 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 595 | 861 | 326 | 96 | 539 |
| Accrued Expenses | 1,560 | 1,871 | 2,153 | 1,937 | 1,711 |
| TOTAL | $2,155 | $2,732 | $2,478 | $2,033 | $2,251 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,155 | $2,732 | $2,478 | $2,033 | $2,251 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,053 | 10,053 | 7,497 | 7,497 | 6,451 |
| Common Shares | 1 | 1 | 75 | 75 | 1 |
| Retained earnings | -38,336 | -34,371 | -29,535 | -25,552 | -21,338 |
| TOTAL | $53,106 | $14,057 | $18,566 | $22,336 | $14,761 |
| Total Liabilities And Equity | $55,261 | $16,788 | $21,044 | $24,369 | $17,012 |